While the High Authority for Health (HAS) should give an opinion on the merits of the reimbursement of homeopathic medicines in June, industry players launched Wednesday a campaign to defend homeopathy. For Christophe Pouchoy, co-manager of the Trecento Santé fund, a possible derogation would not put an industry in good health on the ground today.
